MedPath
NMPA Approval

Recombinant Human Granulocyte Colony-stimulating Factor Injection

国药准字SJ20171037

February 6, 2023

S20171037

Drug Information

重组人粒细胞刺激因子注射液

惠尔血

注射剂

300μg/0.7ml/支

生物制品

February 6, 2023

August 9, 2027

Company Information

Applicant Company

1-9-2 Otemachi, Chiyoda-ku, Tokyo, Japan

Manufacturing Company

nipro pharma corporation ise plant

647-240, Ureshinotengeji-cho, Matsusaka-shi, Mie 515-2302, Japan

© Copyright 2025. All Rights Reserved by MedPath
重组人粒细胞刺激因子注射液 - NMPA 批准文号 | MedPath